Dr. Juan Camilo Arjona Ferreira - 18 Jan 2023 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Chief Medical Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Jan 2023
Net transactions value
-$29,821
Form type
4
Filing time
20 Jan 2023, 15:31:36 UTC
Previous filing
05 Jan 2023
Next filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $29,821 -1,109 -0.45% $26.89 246,684 18 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.